We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
29 Aug 2020 - 02 Sep 2020
Virtual Venue

Single-Port Platform Advances Minimally Invasive Surgery

By HospiMedica International staff writers
Posted on 03 Nov 2016
Print article
Image: The symphonX surgical system for single port laparoscopy (Photo courtesy of Fortimedix Surgical).
Image: The symphonX surgical system for single port laparoscopy (Photo courtesy of Fortimedix Surgical).
An innovative single-port surgical platform emulates conventional multi-port laparoscopy, enabling surgeons to perform procedural steps in a comfortable and secure approach.

The symphonX Surgical Platform enables surgeons to manipulate two laparoscopic instruments at the same time, using controls outside of the body that accurately triangulate the instruments. The design closely mimics traditional laparoscopic equipment, so that the surgeon feels as if he is operating two different tools, each in their own trocar, in a more ergonomic fashion and with fewer complications. Additional benefits include lower usage of analgesics and fewer readmissions for hernias and incision-site infections.

The symphonX Surgical Platform is compatible with a standard 15 mm laparoscopic trocar. The first commercial procedure, with symphonX in the United States a gallbladder extraction, was performed by Professor Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health (UCSD; CA, USA). The symphonX Surgical Platform is a product of Fortimedix Surgical (Nuth, The Netherlands), and has been approved by the U.S. Food and Drug Administration (FDA).

“We are thrilled to formally launch the symphonX Surgical Platform in the United States, which we believe has the potential to deliver on the promise of single-port surgery and elevate the standard of care in laparoscopy,” said Tom Dempsey, VP Sales of Fortimedix Surgical. “Our early clinical experience underlines its potential for improved patient satisfaction and health outcomes, including fewer port-site complications, less post-operative pain, faster recovery and exceptional cosmesis.”

Single-port laparoscopic surgery is used to perform many types of surgery, including adjustable gastric banding, appendectomy, cholecystectomy, hernia repair, hysterectomy, and others. When compared with traditional multi-port laparoscopic techniques, benefits include less postoperative pain, less blood loss, faster recovery time, and better cosmetic results. Despite the potential advantages, there may also be complications, including significant postoperative pain, injury to organs, bleeding, infection, incisional hernia, intestinal adhesions, and scarring.

Related Links:
Fortimedix Surgical


Print article

Channels

Business

view channel
Illustration

Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio

Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.